Mutational Activation of the K-<i>ras</i>Oncogene
Sjoerd Rodenhuis(The Netherlands Cancer Institute), Johannes L. Bos(University Medical Center Utrecht), Nico van Zandwijk(Unknown), Siegina G. Evers, Wolter J. Mooi(The Netherlands Cancer Institute), Marcus L. van de Wetering
Cited by 540
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
|New England Journal of Medicine|1990|811
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
|JNCI Journal of the National Cancer Institute|1998|768
Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
|PubMed|1988|464
Clinical Pharmacokinetics of Cyclophosphamide
|Clinical Pharmacokinetics|2005|451